Clene Inc Stock Alpha and Beta Analysis

CLNN Stock  USD 4.11  0.02  0.48%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Clene Inc. It also helps investors analyze the systematic and unsystematic risks associated with investing in Clene over a specified time horizon. Remember, high Clene's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Clene's market risk premium analysis include:
Beta
1.96
Alpha
(1.20)
Risk
6.4
Sharpe Ratio
(0.16)
Expected Return
(1.01)
Please note that although Clene alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Clene did 1.20  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Clene Inc stock's relative risk over its benchmark. Clene Inc has a beta of 1.96  . As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Clene will likely underperform. As of the 13th of February 2026, Book Value Per Share is likely to grow to -1.39. In addition to that, Tangible Book Value Per Share is likely to grow to -1.39.

Enterprise Value

32.03 Million

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out Clene Analysis, Clene Valuation, Clene Correlation, Clene Hype Analysis, Clene Volatility, Clene Price History and analyze Clene Performance.

Clene Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Clene market risk premium is the additional return an investor will receive from holding Clene long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Clene. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Clene's performance over market.
α-1.2   β1.96

Clene expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Clene's Buy-and-hold return. Our buy-and-hold chart shows how Clene performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Clene Market Price Analysis

Market price analysis indicators help investors to evaluate how Clene stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Clene shares will generate the highest return on investment. By understating and applying Clene stock market price indicators, traders can identify Clene position entry and exit signals to maximize returns.

Clene Return and Market Media

The median price of Clene for the period between Sat, Nov 15, 2025 and Fri, Feb 13, 2026 is 6.23 with a coefficient of variation of 28.54. The daily time series for the period is distributed with a sample standard deviation of 1.84, arithmetic mean of 6.46, and mean deviation of 1.47. The Stock received a lot of media exposure during the period.
 Price Growth (%)  
       Timeline  
1
Analysts Conflicted on These Consumer Goods Names Clene and Target - The Globe and Mail
11/21/2025
2
Disposition of 37235 shares by Ugwumba Chidozie of Clene at 5.94 subject to Rule 16b-3
12/05/2025
3
Disposition of 21463 shares by Ugwumba Chidozie of Clene at 5.7 subject to Rule 16b-3
12/08/2025
4
Disposition of 15031 shares by Ugwumba Chidozie of Clene at 5.95 subject to Rule 16b-3
12/09/2025
5
Disposition of 7603 shares by Ugwumba Chidozie of Clene at 6.79 subject to Rule 16b-3
12/12/2025
6
Disposition of 10580 shares by Ugwumba Chidozie of Clene at 6.49 subject to Rule 16b-3
12/15/2025
7
Disposition of 7030 shares by Ugwumba Chidozie of Clene at 6.31 subject to Rule 16b-3
12/16/2025
8
Disposition of 2884 shares by Ugwumba Chidozie of Clene at 6.61 subject to Rule 16b-3
12/17/2025
9
Disposition of 4367 shares by Ugwumba Chidozie of Clene at 6.54 subject to Rule 16b-3
12/22/2025
10
Disposition of 424358 shares by Ugwumba Chidozie of Clene at 0.001 subject to Rule 16b-3
12/23/2025
11
Disposition of 3350 shares by Ugwumba Chidozie of Clene at 6.32 subject to Rule 16b-3
12/26/2025
12
Disposition of 13095 shares by Ugwumba Chidozie of Clene at 5.81 subject to Rule 16b-3
12/31/2025
13
Disposition of 4015 shares by Ugwumba Chidozie of Clene at 5.73 subject to Rule 16b-3
01/02/2026
14
Disposition of 3111 shares by Ugwumba Chidozie of Clene at 6.04 subject to Rule 16b-3
01/06/2026
15
Disposition of 38 shares by Ugwumba Chidozie of Clene at 6.29 subject to Rule 16b-3
01/07/2026
16
Clene Announces Additional CNM-Au8 Biomarker Data Supporting Potential NDA Filing for Upcoming In-Person FDA Meeting
01/12/2026
17
Disposition of 19621 shares by Ugwumba Chidozie of Clene at 5.12 subject to Rule 16b-3
01/14/2026
18
Disposition of 7923 shares by Ugwumba Chidozie of Clene at 5.13 subject to Rule 16b-3
01/16/2026
19
Disposition of 12119 shares by Ugwumba Chidozie of Clene at 5.05 subject to Rule 16b-3
01/21/2026
20
Acquisition by Etherington Robert Dee of 75000 shares of Clene at 5.42 subject to Rule 16b-3
01/22/2026
21
Disposition of 6418 shares by Ugwumba Chidozie of Clene at 5.02 subject to Rule 16b-3
01/26/2026
22
Disposition of 41 shares by Ugwumba Chidozie of Clene at 5.08 subject to Rule 16b-3
01/27/2026
23
Disposition of 8717 shares by Ugwumba Chidozie of Clene at 4.91 subject to Rule 16b-3
01/28/2026
24
Disposition of 15284 shares by Ugwumba Chidozie of Clene at 4.32 subject to Rule 16b-3
01/29/2026
25
Disposition of 5686 shares by Ugwumba Chidozie of Clene at 4.13 subject to Rule 16b-3
01/30/2026
26
Chidozie Ugwumba Sells 5,686 Shares of Clene Stock
02/02/2026
27
Disposition of 5559 shares by Ugwumba Chidozie of Clene at 4.1 subject to Rule 16b-3
02/03/2026
28
Performance Recap Whats the profit margin of Clene Inc Equity Warrant - 2025 Investor Takeaways Accurate Trade Setup Notifications - baoquankhu1.vn
02/10/2026

About Clene Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Clene or other stocks. Alpha measures the amount that position in Clene Inc has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2023 2024 2025 2026 (projected)
Payables Turnover0.08050.05650.06490.0617
Days Of Inventory On Hand111.61354.57407.76404.35

Clene Upcoming Company Events

As portrayed in its financial statements, the presentation of Clene's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Clene's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Clene's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Clene. Please utilize our Beneish M Score to check the likelihood of Clene's management manipulating its earnings.
11th of March 2024
Upcoming Quarterly Report
View
10th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
11th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with Clene

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Clene Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Clene's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Clene Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Clene Inc Stock:
Check out Clene Analysis, Clene Valuation, Clene Correlation, Clene Hype Analysis, Clene Volatility, Clene Price History and analyze Clene Performance.
You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Clene technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Clene technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Clene trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...